Publication: Desarrollo dental/edad dental en niños con osteogénesis imperfecta tratados con bifosfonatos.
Loading...
Official URL
Full text at PDC
Publication Date
2017
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
(1) Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet .2004;363(9418):1377-1385.
(2) Gutiérrez-Díez M, Gutiérrez MM, Tato LP, García JP, Sánchez AB. Osteogénesis Imperfecta: Nuevas Perspectivas Osteogenesis imperfecta: new insights. Rev Esp Endocrinol Pediatr.2013;4(1):107-118.
(3) Bodian DL, Chan T, Poon A, Schwarze U, Yang K, Byers PH, et al. Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype–phenotype relationships. Hum Mol Genet. 2008;18(3):463-471.
(4) Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med.2006;355(26):2757-2764.
(5) Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol.2008;22(1):85-100.
(6) Hall R, Manière M, Palamara J, Hemmerle J. Odontoblast dysfunction in osteogenesis imperfecta: an LM, SEM, and ultrastructural study. Connect Tissue Res. 2002;43(2-3):401-405.
(7) Fratzl-Zelman N, Misof BM, Roschger P, Klaushofer K. Classification of osteogenesis imperfecta. Wien Med Wochenschr.2015;165(13-14):264-270.
(8) Hoyer-Kuhn H, Netzer C, Semler O. Osteogenesis imperfecta: pathophysiology and treatment. Wien Med Wochenschr. 2015;165(13-14):278-284.
(9) Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet.1979 04;16(2):101-116.
(10) Martínez‐Glez V, Valencia M, Caparrós‐Martín JA, Aglan M, Temtamy S, Tenorio J, et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat .2012;33(2):343-350.
(11) Van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PG, van Rijn RR, et al. Osteogenesis Imperfecta: A Review with Clinical Examples. Mol Syndromol.2011 Dec;2(1):1-20.
(12) Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet .2010;86(4):551-559.
(13) Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002;17(1):30-38.
(14) Ward L, Rauch F, Travers R, Chabot G, Azouz E, Lalic L, et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002;31(1):12-18.
(15) Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat.2008;29(12):1435-1442.
(16)Rohrbach M, Giunta C. Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings. Am J Med Genet C Semin Med Genet.2012; 160C (3):175-89.
(17) Thomas IH, DiMeglio LA. Advances in the classification and treatment of osteogenesis imperfecta. Current osteoporosis reports 2016;14(1):1-9.
(18) Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos 2011; 2011:540178.
(19) Semler O, Cheung MS, Glorieux FH, Rauch F. Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype. Am J Med Genet A. 2010;152 A(7):1681-1687.
(20) Harrington J, Sochett E, Howard A. Update on the evaluation and treatment of osteogenesis imperfecta. Pediatr Clin North Am. 2014;61(6):1243-1257.
(21) Abukabbos H, Al-Sineedi F. Clinical manifestations and dental management of dentinogenesis imperfecta associated with osteogenesis imperfecta: Case report. Saudi Dent J. 2013;25(4):159-165.
(22) Dimasi DP, Chen JY, Hewitt AW, Klebe S, Davey R, Stirling J, et al. Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes. Hum Genet 2010;127(1):33-34.
(23) Evereklioglu C, Madenci E, Bayazıt YA, Yılmaz K, Balat A, Bekir NA. Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera. Ophthalmic Physiol Opt. 2002;22(6):511-515.
(24) Chau FY, Wallace D, Vajaranant T, Herndon L, Lee P, Challa P, et al. Chapter 31-Osteogenesis imperfecta and the eye. En: Shapiro JR,Kassim J, Sponseller PD,editores. Osteogenesis Imperfecta: A translational approach to brittle bone disease.1ra edición. San Diego: Academic press; 2014. p. 289–303.
(25) Paterson CR, Monk EA, McAllion SJ. How common is hearing impairment in osteogenesis imperfecta? J Laryngol Otol.2001;115(4):280-282.
(26) Santos F, McCall AA, Chien W, Merchant S. Otopathology in Osteogenesis Imperfecta. Otol Neurotol. 2012;33(9):1562-1566.
(27) Bonita RE, Cohen IS, Berko BA. Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography. 2010;27(1):69-73.
(28) Hansen B, Jemec GB. The mechanical properties of skin in osteogenesis imperfecta. Arch Dermatol. 2002;138(7):909-911.
(29) LoMauro A, Pochintesta S, Romei M, D'Angelo MG, Pedotti A, Turconi AC, et al. Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta. PloS one 2012;7(4), e35965.
(30) Sillence D. Craniocervical abnormalities in osteogenesis imperfecta: genetic and molecular correlation. Pediatr Radiol. 1994;24(6):427-430.
(31) Ibrahim AG, Crockard HA. Basilar impression and osteogenesis imperfecta: a 21-year retrospective review of outcomes in 20 patients. J Neurosurg Spine. 2007;7(6):594-600.
(32) Vetter U, Pontz B, Zauner E, Brenner RE, Spranger J. Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int. 1992;50(1):36-41.
(33) O’Connell AC, Marini JC. Evaluation of oral problems in an osteogenesis imperfecta population. Oral Surg,Oral Med ,Oral Pathol, Oral Radiol Endod.1999; 87(2):189-196.
(34) Rushton MA. Anomalies of human dentine. Ann R Coll Surg Engl. 1955; 16(2):94-117.
(35) Sunderland EP, Smith CJ. The teeth in osteogenesis and dentinogenesis imperfecta. Br Dent J .1980;149(10):287-289.
(36) Shields E, Bixler D, El-Kafrawy A. A proposed classification for heritable human dentine defects with a description of a new entity. Arch Oral Biol. 1973;18(4):543-553.
(37) Majorana A, Bardellini E, Brunelli PC, Lacaita M, Cazzolla AP, Favia G. Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent. 2010;20(2):112-118.
(38) Malmgren B, Andersson K, Lindahl K, Kindmark A, Grigelioniene G, Zachariadis V, et al. Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes. Oral Dis 2017;23(1):42-49.
(39) Malmgren B, Norgren S. Dental aberrations in children and adolescents with osteogenesis imperfecta. Acta Odontol Scand. 2002 03;60(2):65-71.
(40) Bailleul-Forestier I, Berdal A, Vinckier F, de Ravel T, Fryns JP, Verloes A. The genetic basis of inherited anomalies of the teeth. Part 2: syndromes with significant dental involvement. Eur J Med Genet .2008;51(5):383-408.
(41) Rauch F, Glorieux FH. Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? Ann Med .2005;37(4):295-302.
(42) Thomas IH, DiMeglio LA. Advances in the classification and treatment of osteogenesis imperfecta. Curr Osteoporos Rep. 2016;14(1):1-9.
(43) Montpetit K, Palomo T, Glorieux FH, Fassier F, Rauch F. Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity. Arch Phys Med Rehabil.2015;96(10):1834-1839.
(44) Aizenbud D, Peled M, Figueroa AA. A combined orthodontic and surgical approach in osteogenesis imperfecta and severe Class III malocclusion: case report. J Oral Maxillofac Surg. 2008;66(5):1045-1053.
(45) Hartsfield, J. K., Hohlt, W. F., & Roberts, W. E. Orthodontic treatment and orthognathic surgery for patients with osteogenesis imperfecta. Semin Orthod.2006 ;12:254-271.
(46) Soares AP, do Espírito Santo RF, Line SR, Pinto M, Santos P de M, Toralles MB, et al. Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development. Environ Toxicol Pharmacol. 2016; 42:212-217.
(47) Castillo H, Samson‐Fang L, On behalf of American Academy for Cerebral Palsy and Developmental Medicine Treatment Outcomes Committee Review Panel. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol. 2009;51(1):17-29.
(48) Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med .1998;339(14):947-952.
(49) Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016;10:CD005088.
(50) Chiego DJ, Avery JK Piesco NP, ElNesr NM. Desarrollo de los dientes. En: Chiego DJ, editor. Principios de histología y embriología bucal: Con orientación clínica. 4ta edición. Michigan: Mosby Elsevier; 2014.p.61-76
(51) Wise G, King G. Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res. 2008;87(5):414-434.
(52) Grier IV R, Wise G. Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res .1998;77(1):8-15.
(53) Bradaschia-Correa V, Massa LF, Arana-Chavez VE. Effects of alendronate on tooth eruption and molar root formation in young growing rats. Cell Tissue Res. 2007;330(3):475-485.
(54) Hiraga T, Ninomiya T, Hosoya A, Nakamura H. Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats. Calcif Tissue Int. 2010;86(6):502-510.
(55) Kamoun-Goldrat A, Ginisty D, Le Merrer M. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 2008;116(3):195-198.
(56) Demirjian A, Goldstein H, Tanner JM. A New System of Dental Age Assesment.Ann Hum Biol. 1973;45(2):211-27.
(57) Vuorimies I, Arponen H, Valta H, Tiesalo O, Ekholm M, Ranta H, et al. Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment. Bone 2017; 94:29-33.
(58) Martín De Las Heras S. Estimación de la edad a través del estudio dentario. En: Martínez-Jarreta BM, directora. Ciencia forense. Séptima Edición: Zaragoza: Institución «Fernando el Católico»;2005. p.60-90
(59) Liversidge HM. The assessment and interpretation of Demirjian, Goldstein and Tanner's dental maturity. Ann Hum Biol 2012;39(5):412-431.
(60) Feijóo G, Barbería E, De Nova J, Prieto JL. Dental age estimation in Spanish children. Forensic Sci Int 2012;223(1-3): 371.e1-371.e5.
(61) Lézot F, Chesneau J, Battaglia S, Brion R, Castaneda B, Farges JC, et al. Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. Bone. 2014;68:146-52.